Phio Pharmaceuticals (PHIO) Stock Chart & Stock Price History $3.21 +0.09 (+2.88%) (As of 11/4/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Phio Pharmaceuticals Stock Price Performance5 Day Performance+1.90%1 Month Performance+4.22%3 Month Performance+9.81%6 Month Performance-56.49%Year-To-Date Performance-53.07%1 Year Performance-73.18% Receive PHIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Phio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it. That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain.Here’s the full story for you. PHIO Stock Chart for Monday, November, 4, 2024 PHIO Chart by TradingView Phio Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/04/2024$3.12$3.21+2.88%$3.21$3.075,346 shs$2.76 million11/01/2024$2.98$3.12+4.70%$3.20$2.9519,462 shs$2.69 million10/31/2024$3.15$2.98-5.40%$3.22$2.9134,061 shs$1.52 million10/30/2024$3.29$3.15-4.26%$3.35$3.0672,597 shs$1.61 million10/29/2024$3.01$3.29+9.30%$3.30$2.9176,386 shs$1.68 million10/28/2024$2.91$3.01+3.44%$3.09$2.8910,355 shs$1.54 million Get the Latest News and Ratings for PHIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Phio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/25/2024$2.96$2.91-1.69%$3.04$2.7125,771 shs$1.48 million10/24/2024$2.93$2.96+1.02%$3.17$2.9528,089 shs$2.55 million10/23/2024$3.13$2.93-6.39%$3.05$2.9225,945 shs$2.52 million10/22/2024$3.12$3.13+0.32%$3.29$3.0425,607 shs$2.69 million10/21/2024$2.91$3.12+7.22%$3.25$2.9842,603 shs$1.59 million10/18/2024$2.65$2.91+9.81%$3.00$2.7077,968 shs$2.50 million10/17/2024$3.25$2.65-18.46%$3.33$2.6593,371 shs$1.35 million10/16/2024$2.76$3.25+17.75%$3.88$2.861.08 million shs$2.80 million10/15/2024$2.69$2.76+2.60%$2.86$2.6026,168 shs$2.37 million10/14/2024$2.68$2.69+0.37%$2.70$2.5611,117 shs$2.31 million10/11/2024$2.55$2.68+5.10%$2.69$2.4219,574 shs$2.31 million10/10/2024$2.89$2.55-11.76%$2.92$2.5386,495 shs$2.19 million10/09/2024$2.81$2.89+2.85%$2.99$2.8014,208 shs$1.47 million10/08/2024$2.89$2.81-2.77%$3.04$2.7328,555 shs$2.42 million10/07/2024$3.08$2.89-6.17%$3.17$2.65531,652 shs$2.49 million10/04/2024$3.16$3.08-2.53%$3.26$3.0836,572 shs$2.65 million10/03/2024$3.18$3.16-0.63%$3.28$3.1614,924 shs$2.72 million10/02/2024$3.40$3.18-6.47%$3.47$3.1523,893 shs$2.74 million10/01/2024$3.52$3.40-3.41%$3.61$3.3815,721 shs$1.73 million09/30/2024$3.50$3.52+0.57%$3.74$3.4531,779 shs$3.03 million09/27/2024$3.57$3.50-1.96%$3.61$3.4620,276 shs$1.79 million09/26/2024$3.35$3.57+6.57%$3.57$3.3544,066 shs$3.07 million09/25/2024$3.42$3.35-2.04%$3.61$3.3244,537 shs$2.88 million09/24/2024$3.43$3.42-0.29%$3.55$3.3317,005 shs$1.74 million09/23/2024$3.52$3.43-2.56%$3.67$3.4230,661 shs$1.75 million09/20/2024$3.55$3.52-0.85%$3.69$3.4637,911 shs$3.03 million09/19/2024$3.66$3.55-3.01%$3.70$3.4570,440 shs$1.81 million09/18/2024$3.70$3.66-0.96%$4.00$3.41185,212 shs$1.87 million09/17/2024$3.31$3.70+11.64%$3.95$3.04204,285 shs$1.89 million09/16/2024$3.29$3.31+0.61%$3.38$3.0965,011 shs$2.85 million09/13/2024$2.90$3.30+13.79%$3.47$2.87112,786 shs$2.84 million09/12/2024$2.79$2.90+3.94%$2.90$2.797,688 shs$1.48 million09/11/2024$2.92$2.79-4.45%$2.91$2.745,425 shs$2.40 million09/10/2024$2.78$2.92+5.04%$2.98$2.703,895 shs$2.51 millionThe Final Frontier (Ad)And a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it. That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain.Here’s the full story for you.09/09/2024$2.61$2.78+6.51%$2.86$2.623,961 shs$2.39 million09/06/2024$2.63$2.61-0.76%$2.87$2.5017,596 shs$2.25 million09/05/2024$2.60$2.63+1.15%$2.75$2.606,435 shs$2.26 million09/04/2024$2.67$2.60-2.62%$2.66$2.598,851 shs$2.24 million09/03/2024$2.72$2.67-1.84%$2.80$2.5420,096 shs$1.36 million09/02/2024$2.72$2.72$2.99$2.653,900 shs$2.34 million08/30/2024$2.64$2.78+5.30%$2.99$2.663,945 shs$1.42 million08/29/2024$2.85$2.64-7.37%$2.99$2.6324,446 shs$1.35 million08/28/2024$3.18$2.85-10.38%$3.18$2.7425,750 shs$1.45 million08/27/2024$3.19$3.18-0.31%$3.25$3.132,995 shs$1.62 million08/26/2024$3.25$3.19-1.85%$3.20$3.142,082 shs$1.63 million08/23/2024$3.06$3.25+6.21%$3.29$3.0020,171 shs$1.66 million08/22/2024$3.08$3.06-0.65%$3.09$2.9812,317 shs$1.56 million08/21/2024$3.08$3.08+0.13%$3.19$3.0013,595 shs$1.57 million08/20/2024$3.10$3.08-0.77%$3.16$3.0322,350 shs$1.57 million08/19/2024$2.98$3.10+4.03%$3.29$2.9074,035 shs$1.58 million08/16/2024$2.58$2.98+15.50%$3.10$2.5042,142 shs$1.52 million08/15/2024$2.60$2.58-0.58%$2.63$2.4115,450 shs$1.32 million08/14/2024$2.59$2.60+0.19%$2.65$2.589,825 shs$1.32 million08/13/2024$2.70$2.59-3.90%$2.75$2.5532,535 shs$1.32 million08/12/2024$2.44$2.70+10.45%$2.99$2.5295,230 shs$1.37 million08/09/2024$2.63$2.44-7.22%$2.82$2.4443,906 shs$1.24 million08/08/2024$2.74$2.63-4.01%$2.80$2.4068,087 shs$1.34 million08/07/2024$2.85$2.74-3.86%$3.09$2.7014,783 shs$1.40 million08/06/2024$2.77$2.85+2.89%$2.96$2.6747,517 shs$1.45 million08/05/2024$2.92$2.77-5.24%$2.80$2.6222,742 shs$1.41 million Related Companies VCNX Stock Chart ADIL Stock Chart AEZS Stock Chart ONVO Stock Chart PRTG Stock Chart MBRX Stock Chart ERNA Stock Chart CDIO Stock Chart ORGS Stock Chart SHPH Stock Chart Receive PHIO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Phio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PHIO) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phio Pharmaceuticals Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PHIO Stock Alerts